Page 12 - Sanket Koul

GIC, TPG-backed AHH targets 20 AINU hospitals by FY30, eyes GI entry

AHH aims for 20 nephrology and urology hospitals under AINU by FY30, plans GI expansion, and leaves IPO timing to investor decision despite readiness within 18 months

Poly Medicure to invest ₹500 cr in new plants for global market push

However, this foreign push comes at a time when the device maker is seeing headwinds arising out of short-term demand uncertainties due to on-going geopolitical tensions and tariff issues

Signature Global to launch ₹14,000 crore projects by festive season

Realty firm plans launches in Dwarka Expressway and SPR; Q1 net profit up 386% to ₹34 crore, revenue doubles on project completions and strong sales realisation

Medical devices industry raises concerns over additional 25% US tariff

With US duties on Indian medical devices now at 50%, industry groups warn of trade instability, lost competitiveness, and adverse impact on American patients

Indian pharma market grows 7.9% in July, led by chronic therapies

Despite flat volumes, India's pharma market posted 7.9% growth in July on strong demand for chronic therapies like cardiac and diabetes; MAT turnover crossed Rs 2.3 trillion

Haryana hospitals to continue AB-PMJAY strike despite partial payments

IMA Haryana says hospitals will continue Ayushman Bharat services suspension over Rs 500 crore dues, citing trust deficit with state health agency despite partial repayments

Fortis Q1 profit jumps 53% to ₹267 cr, revenue up 16.6% on strong growth

Fortis Healthcare Q1FY26 profit rises 53% to ₹266.78 crore as hospital and diagnostics businesses drive 16.6% revenue growth and Ebitda margin improves to 22.6%

Eris Lifesciences to target insulin, semaglutide mkt opportunities in FY26

Eris Lifesciences to leverage Novo Nordisk's exit and semaglutide patent expiry, with cartridge capacity and diabetes-focused products planned for commercialisation in FY26

Realty major DLF targets luxury segment launches in the near term

DLF plans ultra-premium launches in FY27, including Golf Course Extension; rental income from Downtown Gurugram and Atrium Place to begin by end-2025

All Kartavya Bhavans may be ready in 2 years: Manohar Lal Khattar

PM Modi to inaugurate the first Common Central Secretariat building, Kartavya Bhavan, on Wednesday as part of the Central Vista plan; others to be ready by 2026

Aurobindo Pharma Q1 PAT falls 10% on drop in API sales, US market revenue

Aurobindo Pharma reports a 10.2% YoY drop in Q1 FY26 PAT due to lower API sales and US market revenue, while its European and growth markets continue to show positive momentum

DLF Q1 FY26 results: PAT up 18% on record sales of over ₹11,425 crore

Revenue nearly doubles to Rs 2,716 crore in Q1 FY26, as DLF meets strong demand for luxury homes and continues expansion in Mumbai, Goa, and Gurugram

Delhi NCR-based Nimbus Group to invest ₹1,100 cr in stalled luxury project

Nimbus Group will invest Rs 1,100 crore to revive the stalled Arista Luxe Phase II project in Noida, aiming for completion by 2029 and offering luxury apartments priced between Rs 4-6 crore

Retail real estate sees higher leasing in H1 2025, driven by stable demand

Retail leasing in India rose 21% in H1 2025 compared to the previous year. Experts predict significant new supplies in Delhi NCR, Mumbai, and Hyderabad in H2 2025.

DRL to Cipla: Pharma Inc firms up plans to launch anti-obesity drugs

Push comes as patents are set to expire in March 2026

Gurugram circle rate hike likely to price out low, mid-income buyers

Gurugram's second circle rate hike in eight months raises acquisition costs and stamp duties, with developers warning of pressure on mid-income housing demand

Mankind Pharma Q1 PAT drops 17.4% despite 24% revenue growth, costs surge

Input and finance costs weigh on profitability; chronic, consumer health and BSV acquisition support top line

Pharma Inc hopes for fair deal as Donald Trump announces 25% tariffs

Trump on Wednesday called India's tariffs on US exports among the highest in the world, with the most strenuous non-monetary trade barriers of any country, in a post on Truth Social

Healthcare body seeks regulatory reforms in meeting with Niti Aayog

Nathealth has proposed a digital single-window system to Niti Aayog to ease the healthcare sector's compliance load, citing inefficiencies and duplication across ministries

Torrent Pharma Q1 results: PAT up 20% on robust sales across territories

Torrent Pharmaceuticals reports Rs 548 crore Q1 net profit, led by strong growth in India, the US, and Brazil, with chronic therapies and top brands driving momentum